MetabolismNews.net

Metabolism Xagena

Search results for "Fosamax"

Twice-yearly subcutaneous injections of Denosumab ( 60 mg; Prolia ) increased bone mineral density ( BMD ) in the lumbar spine, total hip, distal 1/3 radius and total body compared to placebo at 24 mo ...


Researchers at the Stanford University School of Medicine have found that a new osteoporosis drug, called Teriparatide ( Forteo ), is not cost-effective compared with the most commonly prescribed oste ...


Alendronate ( Fosamax ), a medication used to prevent fractures in women with osteoporosis, may be associated with an increased risk of atrial fibrillation. Other recent studies have reported atria ...


Researchers found patients with glucocorticoid-induced osteoporosis who were treated with Teriparatide ( Forteo, Forsteo ) for 36 months had a greater increase in bone mineral density ( BMD ) and fewe ...


The results from a phase II trial for Odanacatib, a cathepsin K ( cat-K ) inhibitor in development for the treatment of osteoporosis in post-menopausal women, were presented at the 34th Annual Meeting ...


The results from a phase 2 trial evaluating Romosozumab in postmenopausal women with low bone mineral density ( BMD ) were published in the New England Journal of Medicine ( NEJM ).The trial demonstra ...